Board of ERIS Lifesciences approves appointment of directors

The Board of ERIS Lifesciences has approved the appointment of Rajeev Dalal (DIN : 00222650) as an gAdditional Director (Non]Executive Independent Director)h on the Board of Directors of the Company with effect from 19 December 2020 for a term of 5 (five) years upto 18 December 2025, subject to approval of the Shareholders of the Company.

Powered by Capital Market - Live News